Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06523621
Title Nivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wake Forest University Health Sciences
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston-Salem North Carolina 27103 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field